Benzinga’s Top Ratings Upgrades, Downgrades For October 2, 2023
Upgrades For Invitation Homes Inc (NYSE:INVH), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. For…
FedEx – HSBC Forecasts Dips In CapEx Intensity And Strong Growth In Small Parcels & Freight
HSBC analysts Parash Jain, Deepak Maurya and Bruce Chu initiated coverage on FedEx Corp (NYSE: FDX) with a Buy rating and a
Ingredion’s Growth Strategy To Please Health-Conscious Consumers Can Make It A Winner: Analyst
Oppenheimer analyst Kristen Owen initiated coverage on Ingredion Inc (NYSE: INGR) with an Outperform rating
AbbVie’s Promising Leap Towards Long-Term Growth: Analyst
Raymond James initiated coverage on AbbVie Inc (NYSE: ABBV) as the company looks beyond Humira's loss of exclusivity and has several levers to set up long-term growth.
Fusion Pharmaceuticals Poised For Leadership In Targeted Cancer Therapies: Oppenheimer
Oppenheimer initiated coverage on Fusion Pharmaceuticals Inc (NASDAQ: FUSN), citing the company's pipeline as among the best in the space with alpha-emitter-based targeted radionuclide therapies (TRTs), with three currently in clinical development.
Benzinga’s Top Ratings Upgrades, Downgrades For September 29, 2023
Upgrades For Nike Inc (NYSE:NKE), Williams Trading upgraded the previous rating of Sell to Hold. Nike earned $0.94…
Dianthus’ Monoclonal Antibody On Promising Pathway To Gaining The Upper Hand – Analyst
Raymond James initiated coverage on Dianthus Therapeutics Inc (NASDAQ: DNTH), a recent reverse merger with the old Magenta Therapeutics.
Tetra’s Diversified Future: Lithium, Zinc Bromide, And Water Recycling Poised To Reshape Earnings, Highlights Analyst
Benchmark analyst Kurt Hallead initiated coverage on Tetra Technologies Inc (NYSE: TTI) with a Buy rating
Impact on BioMarin’s Sentiment: Voxzogo’s Triumph Clouded by Uncertainty
Raymond James initiated coverage on BioMarin Pharmaceuticals Inc (NASDAQ: BMRN) with a Market Perform rating, noting sparsity in
Ciena Analyst Predicts Gains From Strong Bandwidth Growth
Shares of Ciena Corporation (NYSE: CIEN) climbed in early trading on Thursday.
Strong bandwidth growth should be a longer-term tailwind for the company, according to Stifel.